nodes	percent_of_prediction	percent_of_DWPC	metapath
Lornoxicam—PTGS2—osteoarthritis	0.96	1	CbGaD
Lornoxicam—Tenoxicam—PTGS2—osteoarthritis	0.00313	0.429	CrCbGaD
Lornoxicam—PTGS2—skeletal joint—osteoarthritis	0.00305	0.243	CbGeAlD
Lornoxicam—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGES—osteoarthritis	0.00254	0.124	CbGpPWpGaD
Lornoxicam—PTGS2—leg—osteoarthritis	0.00233	0.186	CbGeAlD
Lornoxicam—PTGS2—synovial membrane of synovial joint—osteoarthritis	0.00231	0.185	CbGeAlD
Lornoxicam—Meloxicam—PTGS2—osteoarthritis	0.00223	0.306	CrCbGaD
Lornoxicam—PTGS2—hindlimb—osteoarthritis	0.00208	0.166	CbGeAlD
Lornoxicam—PTGS2—cartilage tissue—osteoarthritis	0.00205	0.163	CbGeAlD
Lornoxicam—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGES—osteoarthritis	0.00201	0.0981	CbGpPWpGaD
Lornoxicam—Piroxicam—PTGS2—osteoarthritis	0.00194	0.265	CrCbGaD
Lornoxicam—PTGS1—Eicosanoid Synthesis—PTGES—osteoarthritis	0.00165	0.0803	CbGpPWpGaD
Lornoxicam—PTGS2—Eicosanoid Synthesis—PTGES—osteoarthritis	0.00131	0.0637	CbGpPWpGaD
Lornoxicam—PTGS1—Arachidonic acid metabolism—PTGES—osteoarthritis	0.000916	0.0446	CbGpPWpGaD
Lornoxicam—PTGS2—Arachidonic acid metabolism—PTGES—osteoarthritis	0.000727	0.0354	CbGpPWpGaD
Lornoxicam—PTGS1—Overview of nanoparticle effects—CRP—osteoarthritis	0.000581	0.0283	CbGpPWpGaD
Lornoxicam—PTGS1—Overview of nanoparticle effects—FN1—osteoarthritis	0.000536	0.0261	CbGpPWpGaD
Lornoxicam—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—osteoarthritis	0.000535	0.0261	CbGpPWpGaD
Lornoxicam—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—osteoarthritis	0.000498	0.0242	CbGpPWpGaD
Lornoxicam—CYP2C9—Arachidonic acid metabolism—PTGES—osteoarthritis	0.000482	0.0235	CbGpPWpGaD
Lornoxicam—PTGS2—Overview of nanoparticle effects—CRP—osteoarthritis	0.000461	0.0225	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—SOX9—osteoarthritis	0.000449	0.0219	CbGpPWpGaD
Lornoxicam—PTGS2—Overview of nanoparticle effects—FN1—osteoarthritis	0.000426	0.0207	CbGpPWpGaD
Lornoxicam—PTGS1—Overview of nanoparticle effects—PTGS2—osteoarthritis	0.00039	0.019	CbGpPWpGaD
Lornoxicam—PTGS1—Overview of nanoparticle effects—CXCL8—osteoarthritis	0.000378	0.0184	CbGpPWpGaD
Lornoxicam—PTGS1—tendon—osteoarthritis	0.000366	0.0292	CbGeAlD
Lornoxicam—PTGS2—tendon—osteoarthritis	0.00035	0.0279	CbGeAlD
Lornoxicam—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—GSTO1—osteoarthritis	0.000329	0.016	CbGpPWpGaD
Lornoxicam—PTGS1—Eicosanoid Synthesis—PTGS2—osteoarthritis	0.000323	0.0157	CbGpPWpGaD
Lornoxicam—PTGS2—Overview of nanoparticle effects—CXCL8—osteoarthritis	0.0003	0.0146	CbGpPWpGaD
Lornoxicam—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—osteoarthritis	0.00027	0.0132	CbGpPWpGaD
Lornoxicam—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—osteoarthritis	0.000264	0.0129	CbGpPWpGaD
Lornoxicam—PTGS1—Overview of nanoparticle effects—TNF—osteoarthritis	0.000263	0.0128	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—GSTO1—osteoarthritis	0.00024	0.0117	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—COL2A1—osteoarthritis	0.000238	0.0116	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—ESR1—osteoarthritis	0.000213	0.0103	CbGpPWpGaD
Lornoxicam—PTGS1—Overview of nanoparticle effects—IL6—osteoarthritis	0.000212	0.0103	CbGpPWpGaD
Lornoxicam—PTGS2—Overview of nanoparticle effects—TNF—osteoarthritis	0.000209	0.0102	CbGpPWpGaD
Lornoxicam—PTGS1—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.00018	0.00875	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—CRP—osteoarthritis	0.000171	0.0083	CbGpPWpGaD
Lornoxicam—PTGS2—Overview of nanoparticle effects—IL6—osteoarthritis	0.000169	0.00821	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—osteoarthritis	0.000138	0.00674	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—CRP—osteoarthritis	0.000135	0.00659	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000131	0.00638	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—IL1A—osteoarthritis	0.000128	0.00624	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—GSTO1—osteoarthritis	0.000126	0.00615	CbGpPWpGaD
Lornoxicam—CYP2C9—Metapathway biotransformation—GSTO1—osteoarthritis	0.000125	0.00607	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—PTGS2—osteoarthritis	0.000114	0.00557	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—IL1B—osteoarthritis	0.000106	0.00518	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—LEP—osteoarthritis	0.000105	0.0051	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000104	0.00506	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—TNF—osteoarthritis	0.000103	0.00501	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoarthritis	9.63e-05	0.00469	CbGpPWpGaD
Lornoxicam—CYP2C9—Arachidonic acid metabolism—PTGS2—osteoarthritis	9.45e-05	0.0046	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—IL1B—osteoarthritis	8.45e-05	0.00411	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—TNF—osteoarthritis	7.72e-05	0.00376	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—FMOD—osteoarthritis	7.15e-05	0.00348	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—CXCL8—osteoarthritis	6.96e-05	0.00339	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	6.88e-05	0.00335	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	6.8e-05	0.00331	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—FMOD—osteoarthritis	6.78e-05	0.0033	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—IL1B—osteoarthritis	6.68e-05	0.00325	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—MMP9—osteoarthritis	6.3e-05	0.00307	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—IL6—osteoarthritis	6.23e-05	0.00303	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—TNF—osteoarthritis	6.13e-05	0.00298	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—IHH—osteoarthritis	6.04e-05	0.00294	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	5.89e-05	0.00287	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PTGES—osteoarthritis	5.83e-05	0.00284	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—FMOD—osteoarthritis	5.68e-05	0.00277	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—TGFB1—osteoarthritis	5.19e-05	0.00253	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—IL6—osteoarthritis	4.95e-05	0.00241	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—TNF—osteoarthritis	4.85e-05	0.00236	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PTGES—osteoarthritis	4.63e-05	0.00225	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—TGFBI—osteoarthritis	4.51e-05	0.00219	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GSTO1—osteoarthritis	4.11e-05	0.002	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—BGN—osteoarthritis	3.98e-05	0.00194	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—IL6—osteoarthritis	3.91e-05	0.0019	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—GSTO1—osteoarthritis	3.89e-05	0.0019	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—BGN—osteoarthritis	3.77e-05	0.00184	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—FMOD—osteoarthritis	3.76e-05	0.00183	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	3.53e-05	0.00172	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	3.3e-05	0.00161	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GSTO1—osteoarthritis	3.26e-05	0.00159	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—BGN—osteoarthritis	3.16e-05	0.00154	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PTGES—osteoarthritis	3.07e-05	0.00149	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	2.57e-05	0.00125	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTO1—osteoarthritis	2.16e-05	0.00105	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—BGN—osteoarthritis	2.09e-05	0.00102	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SMAD3—osteoarthritis	1.85e-05	0.000902	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	1.35e-05	0.000658	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PTGS2—osteoarthritis	1.14e-05	0.000557	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—TGFB1—osteoarthritis	7.84e-06	0.000382	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PTGS2—osteoarthritis	6.01e-06	0.000293	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—IL6—osteoarthritis	5.91e-06	0.000288	CbGpPWpGaD
